April 3, 2022
BMS study show improvements in cardiovascular outcomes in certain patients getting Mavacamten
BMS has published data showing treatment with mavacamten showed sustained improvement in left ventricular outflow tract (LVOT) gradients, New York Heart Association (NYHA) Class and N-terminal pro brain natriuretic peptide (NT-proBNP) levels.